Journal article · 2025 · Open access

Determinants of perceived patient benefit in a longitudinal cohort study of patients with psoriasis and atopic dermatitis

Gloria‐Beatrice Wintermann, Susanne Abraham, Eva M.J. Peters, Stefan Beissert, Kerstin Weidner

Scientific Reports, 15(1), 1553 · Published 10 January 2025 · DOI 10.1038/s41598-024-84794-2

Open PDFView at the publisherCite this paper

In brief

“Determinants of perceived patient benefit in a longitudinal cohort study of patients with psoriasis and atopic dermatitis” is a 2025 journal article by Gloria‐Beatrice Wintermann and 4 co-authors, published in Scientific Reports. OpenAlex counts 2 citations as of 22 November 2026, which puts it in the top 6% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Scientific Reports.

Citations
2
Most cited in
2026 (2)
Field-weighted impact
0.55
References
60
Authors
5

Abstract

The Dermatology Life Quality Index (DLQI) should be used to assess treatment success in psoriasis (PSO). However, the DLQI does not assess the importance and achievement of treatment goals. The Patient Benefit Index (PBI) is a questionnaire that takes both into account. Currently, there is insufficient knowledge about the modulating variables of the PBI and whether it can complement the assessment of the DLQI. In a longitudinal cohort study, 82 patients with PSO were assessed before and up to sixteen weeks after a new treatment episode. The PBI was compared with patients with atopic dermatitis (AD) (n = 61). The effects of gender, age, type of therapy, improvement in body surface area (BSA), anxiety/depression, DLQI and individual coping were assessed. "Getting better skin quickly" was most important in PSO. Improved BSA, anxiety/depression, DLQI, male gender and initiation of biological therapy had the most positive effects. Partial mediation was found for the reduction of anxiety/depression and improved coping. The PBI may be considered an appropriate outcome measure of treatment success in PSO, complementing the DLQI. Patients with clinically relevant anxiety/depression and inadequate coping should be offered adjuvant psychosomatic treatment.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Wintermann, G., Abraham, S., Peters, E. M., Beissert, S., & Weidner, K. (2025). Determinants of perceived patient benefit in a longitudinal cohort study of patients with psoriasis and atopic dermatitis. Scientific Reports, 15(1), 1553. https://doi.org/10.1038/s41598-024-84794-2

MLA 9

Wintermann, Gloria‐Beatrice, et al. “Determinants of perceived patient benefit in a longitudinal cohort study of patients with psoriasis and atopic dermatitis.” Scientific Reports, vol. 15, no. 1, 2025, p. 1553. https://doi.org/10.1038/s41598-024-84794-2.

Chicago

Wintermann, Gloria‐Beatrice, Susanne Abraham, Eva M.J. Peters, Stefan Beissert, and Kerstin Weidner. 2025. “Determinants of perceived patient benefit in a longitudinal cohort study of patients with psoriasis and atopic dermatitis.” Scientific Reports 15 (1): 1553. https://doi.org/10.1038/s41598-024-84794-2.

Harvard

Wintermann, G. et al. (2025) ‘Determinants of perceived patient benefit in a longitudinal cohort study of patients with psoriasis and atopic dermatitis’, Scientific Reports, 15(1), p. 1553. doi:10.1038/s41598-024-84794-2.

IEEE

G. Wintermann, S. Abraham, E. M. Peters, S. Beissert, and K. Weidner, “Determinants of perceived patient benefit in a longitudinal cohort study of patients with psoriasis and atopic dermatitis,” Scientific Reports, vol. 15, no. 1, p. 1553, 2025, doi: 10.1038/s41598-024-84794-2.

BibTeX

@article{wintermann2025determinants,
  title     = {{Determinants of perceived patient benefit in a longitudinal cohort study of patients with psoriasis and atopic dermatitis}},
  author    = {Wintermann, Gloria‐Beatrice and Abraham, Susanne and Peters, Eva M.J. and Beissert, Stefan and Weidner, Kerstin},
  journal   = {Scientific Reports},
  year      = {2025},
  volume    = {15},
  number    = {1},
  pages     = {1553},
  doi       = {10.1038/s41598-024-84794-2},
  url       = {https://doi.org/10.1038/s41598-024-84794-2}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis

  • psoriasis
  • atopic dermatitis
  • Patient Benefit Index
  • Dermatology Life Quality Index
  • treatment success
  • patient-reported outcomes
  • anxiety and depression
  • coping

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Wintermann, G., Abraham, S., Peters, E. M., Beissert, S., & Weidner, K. (2025). Determinants of perceived patient benefit in a longitudinal cohort study of patients with psoriasis and atopic dermatitis. Scientific Reports, 15(1), 1553. https://doi.org/10.1038/s41598-024-84794-2

How many times has this paper been cited?

2 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Scientific Reports: sign in and open the PDF from this page.

Who wrote this paper?

Gloria‐Beatrice Wintermann, Susanne Abraham, Eva M.J. Peters, Stefan Beissert, Kerstin Weidner.

What is the DOI of this paper?

10.1038/s41598-024-84794-2, permanently at https://doi.org/10.1038/s41598-024-84794-2. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.